Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Cell & Bioscience

Fig. 3

From: A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease

Fig. 3

Upregulation of the T-cell PD-L1 immune checkpoint status was detected in the moderate stage of AD. A Comparison of T-cell subset proportions among healthy volunteers, mild AD patients, and moderate AD patients. B Comparison of CD8+CD25+ T-cell population among healthy volunteers, mild AD patients, and moderate AD patients. C The median fluorescence intensity of PD-L1 expressed on T-cell subsets in healthy volunteers, mild AD patients, and moderate AD patients. D, E The percentage of the PD-L1+ population in its subset and PBMCs in healthy volunteers, mild AD patients, and moderate AD patients. A Mann‒Whitney U test was used to compare healthy volunteers (n = 16), mild AD patients (n = 10), and moderate AD patients (n = 6); median values are indicated by thick black lines in the scatter plots. *p < 0.05, **p < 0.01

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us